ALIYA MALLETT: Open Payments
NPI 1932857083 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 13 payments from 9 companies in 2025. Trend: 2023 $223 · 2024 $183 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $62 |
| Verrica Pharmaceuticals Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Cranial Technologies, Inc | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Corium, LLC | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
Products named: Qelbree, YCANTH, Doc Band, TZIELD, NEFFY, VAXELIS, Azstarys, Jornay PM.
Industry payments across MA — which companies pay providers there.
